- News
-
- Sport
-
- Entertainment
-
- Advice
-
- Roots
-
Make a comment
Larger Text
Print
E-mailJohnson & Johnson buy $1.5 billion stake in Irish biotech Elan
Johnson & Johnson has bought all of Elan’s Assets in their Alzheimer's Immunotherapy Program for $1 billion and will receive 18.4 percent of company shares as part of the deal.
JNJ will also pump $500 million into a new company to continue the development of the Elan and Wyeth's drug bapineuzumab, which is said to combat the spread of Alzheimer's.
JNJ and Elan will split equity in the company 50.1/49.9 per cent respectively.
Elan and Wyeth created bapineuzumab together and Johnson & Johnson confirmed they would continue to work with Wyeth on these projects.
Elan has its headquarters in Dublin and this deal comes at a good time, as the company was suffering from high debt and had been sending out feelers in the market that it was open for offers.
Related Items
Most Popular News Stories
Most Recent Blog Posts
Join us - follow IrishCentral.com
Click here to read more about IrishCentral.com.
About Us
IrishCentral is the website about everything Irish for everyone Irish -- the 70 million people around the world who trace their roots to the Emerald Isle.You'll find the most-fascinating stories from the United States, Ireland and the global Irish world, including the latest in news, entertainment, celebrity gossip, travel and vacations, sports, food and drink, Irish ancestry and genealogy, immigration, religion, business and opinion. (close)
